Get the Stockscreener App
6.99
9.73%
0.62
After Hours:
6.99
Neuropace Inc stock is traded at $6.99, with a volume of 103.41K.
It is up +9.73% in the last 24 hours and up +2.34% over the past month.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
See More
Previous Close:
$6.37
Open:
$6.27
24h Volume:
103.41K
Relative Volume:
1.57
Market Cap:
$193.28M
Revenue:
$65.42M
Net Income/Loss:
$-32.96M
P/E Ratio:
-4.1118
EPS:
-1.7
Net Cash Flow:
$-19.87M
1W Performance:
+7.70%
1M Performance:
+2.34%
6M Performance:
-48.75%
1Y Performance:
-2.51%
1-Day Range:
$6.27
$7.15
1-Week Range:
$6.03
$7.15
52-Week Range:
$5.45
$18.15
Neuropace Inc Stock (NPCE) Company Profile
Name
Neuropace Inc
Sector
Industry
Phone
(650) 237-2700
Address
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-24-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-22-23 | Initiated | Lake Street | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Jan-19-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-11-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-18-21 | Initiated | Robert W. Baird | Outperform |
| May-17-21 | Initiated | JP Morgan | Overweight |
| May-17-21 | Initiated | Morgan Stanley | Overweight |
| May-17-21 | Initiated | SVB Leerink | Outperform |
| May-17-21 | Initiated | Wells Fargo | Overweight |
View All
Neuropace Inc Stock (NPCE) Latest News
NeuroPace (NPCE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy - ForexTV.com
NeuroPace submits RNS System study data to FDA - Investing.com
How to Take Advantage of moves in (NPCE) - Stock Traders Daily
Analysts Set NeuroPace, Inc. (NASDAQ:NPCE) Target Price at $14.00 - Defense World
NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? - MSN
Deep Brain Stimulation Devices Market Growing Popularity & Emerging Trends | Medtronic, NeuroPace, LivaNova - openPR
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
Neuropace shareholder KCK Ltd. sells $1.22 million in stock By Investing.com - Investing.com South Africa
Neuropace shareholder KCK Ltd. sells $1.22 million in stock - Investing.com
Ltd. Kck Sells 223,991 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stock - MarketBeat
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Neuropace Inc sees $24,853 stock sale by major shareholder - Investing.com
Page 85 – Impact Investing - Equities News
Neuropace stock hits 52-week low at $5.66 amid market challenges - Investing.com Australia
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 - The Manila Times
Neuropace sees $53,370 in stock sales by major shareholder - Investing.com
NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Ltd. Kck Sells 3,720 Shares - MarketBeat
Neuropace Inc: KCK Ltd. sells $303,366 in shares By Investing.com - Investing.com South Africa
Neuropace Inc: KCK Ltd. sells $303,366 in shares - Investing.com India
KCK LTD. Reduces Stake in NeuroPace Inc - GuruFocus.com
Insider Selling: NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells 2,572 Shares of Stock - MarketBeat
NeuroPace Continues to Strengthen Management Team - The Manila Times
NeuroPace appoints new VP of Human Resources - Investing.com
NeuroPace appoints new VP of Human Resources By Investing.com - Investing.com UK
Marshall Wace LLP Sells 26,313 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Millennium Management LLC Acquires 80,324 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
Augmented Humanity Technologies Industry to Witness Growth Acceleration by (2024-2034) - IndiaPolitics.com
Brain Computer Interface (BCI) Industry – Key Innovations and Future Market Scope - TIMC
Neurostimulation Devices Market is Estimated to Reach $11.26 Billion By 2032 - 대구포스트
Implantable Pulse Generator Market Report 2024: Size, Share, Growth, Forecast to 2033 - WhaTech
Neuroscience Industry Report By Type, Application and Geography - Elektrotransports.lv
Digital Health Monitoring Devices Industry Business Development, Trends - Elektrotransports.lv
Cubist Systematic Strategies LLC Decreases Stock Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Matthias Stangl Receives R00 Grant from NIH - Boston University
Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Target Price at $14.00 - MarketBeat
Down Over 60% In 3 Months, Will NeuroPace Stock Regain Its Pace? - RTTNews
Trading (NPCE) With Integrated Risk Controls - Stock Traders Daily
Nantahala Capital Management LLC Reduces Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
XTX Topco Ltd Increases Stock Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Rhumbline Advisers Takes $111,000 Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
NeuroPace's SWOT analysis: epilepsy device maker's stock poised for growth By Investing.com - Investing.com Australia
NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up - MSN
34,059 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Acquired by Bank of New York Mellon Corp - Defense World
BCI and EEG Market Future Developments, Upcoming Trends, and Top-Vendor Landscape 2020 to 2032 Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc – Cauverynews - Cauverynews
National Bank of Canada (OTCMKTS:NTIOF) Hits New 1-Year High at $94.20 - Defense World
Understanding the Risks of Investing in Noble Corp Plc (NE) - Knox Daily
Nothing is Better Than New Found Gold Corp (NFGC) stock at the moment - SETE News
Internal Neuromodulation Devices Market Size, Trends And Forecast 2024-2033 - WhaTech
Avoro Capital Advisors LLC Makes New Investment in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neuropace Inc Stock (NPCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuropace Inc Stock (NPCE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| KCK LTD. | 10% Owner |
Oct 23 '24 |
Sale |
6.02 |
147 |
885 |
5,494,836 |
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):